comparemela.com
Home
Live Updates
Proteomics International Laboratories Ltd (ASX:PIQ) Canagliflozin Lowers PromarkerD DKD Risk Prediction Scores : comparemela.com
Proteomics International Laboratories Ltd (ASX:PIQ) Canagliflozin Lowers PromarkerD DKD Risk Prediction Scores
Proteomics International Laboratories Ltd (ASX:PIQ) is pleased to announce results showing a significant reduction in the PromarkerD risk scores of patients with type 2 diabetes after taking the diabetes medicine canagliflozin.
Related Keywords
Australia ,
United States ,
Perth ,
Western Australia ,
Richard Lipscombe ,
Janssen Research Development ,
Rj Lipscombe Proteomics International ,
Proteomics International Laboratories Ltd ,
Proteomics International ,
Janssen Research ,
University Of Western Australia ,
Canagliflozin Lowers Promarkerd ,
International Laboratories Ltd ,
Clinical Medicine ,
Precision Medicine ,
Vascular Assessment Study ,
Australasian Diabetes Conference ,
Editorial Board ,
Medical School ,
Fremantle Hospital ,
Spring House ,
Vas Cular Assessment Study ,
Print This ,
Page Viewed ,
Biotech ,
Health Pharm Generalproteomics International Laboratories Ltd ,
Asx Piq ,
comparemela.com © 2020. All Rights Reserved.